CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings

Core Insights - CareDx, Inc. is a leading precision medicine company focused on healthcare solutions for transplant patients and caregivers [1] Group 1 - The company announced pivotal clinical validation data from the ACROBAT study (NCT04635384) [1] - This data will be presented at the 2026 Tandem Meetings, Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® [1]